News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

North American Drug Delivery Technologies Market Worth $102.2 Billion by 2017: MarketsandMarkets


10/8/2013 9:36:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time consuming than a novel drug delivery technology. Therefore, in recent years, several pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs, the patents for which are set to expire in the near future.

The North American drug delivery market was estimated to be worth $66.7 billion in 2012, and is expected to register a CAGR of 8.9% between 2012 and 2017. Based on the route of administration, the drug delivery market has been classified as oral, pulmonary, injectable, transdermal, implantable, ocular, nasal, transmucosal, and topical. In 2012, oral drug delivery segment dominated the market with a share of approximately 38%, followed by pulmonary drug delivery segment with a 20% share.

The drug delivery technologies that have recently gained importance in the North American market include orodispersible tablet (ODT), dry powder inhalers, transdermal patches, needle-free injectors, auto and pen injectors, and buccal transmucosal tablets; controlled release is the most widely accepted technology. The use of implantable devices for drug delivery is also on a rise.

Big pharmaceutical companies such as Pfizer and Merck have established in-house capabilities for the development of drug delivery technologies. On the contrary, many other companies are still relying on specialty companies engaged in the development of drug delivery technologies. High level of competition and increasing need for outsourcing has resulted in the drug delivery market to be fragmented, with several small companies developing novel drug delivery technologies for niche therapeutic applications.

The North American drug delivery market is largely dominated by the U.S. (accounting for about 89% of the overall market). The key drivers for the U.S. drug delivery market are the well established pharmaceutical industry , healthcare reforms, and favourable changes in the FDA review process. Factors such as low cost drug manufacturing and rising number of drug delivery formulations and devices are propelling the Canadian market.

Key players in the drug delivery technologies market are 3M Company (U.S.), Aptalis Pharma, Inc. (U.S.), Baxter International, Inc. (U.S.), Becton, Dickinson & Co. (U.S.), Catalent Pharma Solutions (U.S.), The Dow Chemical Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Nektar Therapeutics (U.S.) and Valeant Pharmaceuticals (Canada).

Scope of the Report

This research report categorizes and analyzes the North American Drug Delivery Technologies market on the basis of routes of administration. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by country (U.S and Canada), to provide in-depth information on the North American market scenario.

North American drug delivery technologies market, by segment:

Oral Drug Delivery

Controlled Release

Orodispersible Tablets (ODT) and Taste Masking

Others

Pulmonary Drug Delivery

Dry Powder Inhalers

Metered Dose Inhalers

Nebulizers

Transdermal Drug Delivery

Passive Drug Delivery

Reservoir System

Matrix System

Active Drug Delivery

Iontophoresis

Microporation

Others

Injectable Drug Delivery

Conventional Injection Devices

Fillable Syringes

Prefilled Syringes

Self-injection Devices

Needle-free Injectors

Auto-injectors or Safety Syringe Devices

Pen Injectors

Others

Ocular Drug Delivery

Eye Drops

Ointment and Gel

Others

Nasal Drug Delivery

Nasal Drops

Nasal Sprays

Nasal Inhalers

Others

Topical Drug Delivery

Liquid Formulations

Semisolid Formulations

Solid Formulations

Implantable Drug Delivery

Drug-Eluting Stents

Implantable Infusion Pumps

Contraceptive Implants

Intravitreal Implants

Brachytherapy Seeds

Transmucosal Drug Delivery

Oral (Buccal and Sublingual)

Others (Rectal and Vaginal)

North America drug delivery technologies market, by country:

U.S

Canada

Customer Interested in this report also can view

European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017

Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES